Clinical Trial Update: Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ticagrelor with aspirin for prevention of vascular events in patients undergoing CABG was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Stable Angina

Drugs mentioned

• Aspirin (Aspirin)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Artery Disease, Stable Angina | Phase 3 | Status: TERMINATED